March 13, 2026

RSV Vaccine Eligibility Expands

Trial data show noninferior immune response in high-risk adults aged 18 to 49 years.

Conexiant

March 09, 2026

CDC Mobilizes Federal Support for Measles Outbreaks

Federal disease detectives deploy to South Carolina as CDC expands its multistate containment strategy

Conexiant

February 27, 2026

ACOG Parts Ways With ACIP

“ACOG’s withdrawal from ACIP is not a withdrawal from our commitment to advancing vaccine science or to protecting patients’ health and safety."

Conexiant

February 27, 2026

MHRA Approval for First UK-made mRNA Vaccine

Moderna receives MHRA approval for updated COVID-19 vaccine targeting SARS-CoV-2 variant LP.8.1

The Medicine Maker

February 13, 2026

What Was Promised at Confirmation?

After pledging to uphold vaccine policy and funding, RFK Jr. has reshaped advisory panels, research priorities, and immunization guidance.

KFF Health News

February 11, 2026

AMA Backs Structured Vaccine Review

Medical societies and public health groups will collaborate on policy questions and evidence briefs for the 2026 to 2027 respiratory virus season.

Conexiant

February 10, 2026

Why Scientists Are Revisiting a Polarizer

The nation’s top cancer institute takes a closer look at a disputed drug.

KFF Health News

February 04, 2026

FDA Expands HPV Primary Screening Options

Regulatory action broadens available approaches for cervical cancer screening in US clinical practice.

Conexiant

January 30, 2026

Hospitals, Custody, and the Missing Patient

As detained patients enter hospitals, access to care, communication, and advocacy becomes unclear.

KFF Health News

January 27, 2026

CDC Database Pauses Raise Concerns

Researchers review the scope and characteristics of unexplained pauses in CDC surveillance databases and examine potential implications for public health monitoring.

Conexiant